National Consumers League

From the Experts Blog

NCL staff is hard at work for you playing watchdog on a variety of issues. Get to know the latest From the Experts!

For the Children’s Health Insurance Program, no news is NOT good news

92_johnson-300.jpgSince its enactment in 1997, the Children’s Health Insurance Program (CHIP), which provides health coverage for low-income children, has enjoyed broad bipartisan support in Congress and in turn, been reauthorized regularly without issue--until now. It’s been more than two months since the September 30 deadline to reauthorize CHIP came and went without any Congressional action. While lawmakers maintain that CHIP will be reauthorized eventually, for the nine million children and pregnant women that rely on the program for their healthcare, “eventually” may be too late.

Read More →


We must not leave farmworker women out of the harassment discussion

norma.jpgNorma Flores López is a member of the National Consumers League's Board of Directors. She is also the Governance and Collaboration/Development Manager of the East Coast Migrant Head Start Project.

Today’s headlines and top hashtags are showing that a powerful movement is building, and its being led by women.

Read More →


Holiday shopping? Some strategies to consider if you are concerned about child labor

maki.jpgWith the holidays approaching and many Americans scrambling to buy presents, we get many questions from consumers who are interested in shopping responsibly. Newly released data suggests that there are about 40 million individuals in forced labor and 152 million children who are trapped in child labor around the world today. How can one avoid buying products that may contribute to this rampant exploitation?

Read More →



NCL encouraged by FDA Commissioner Gottlieb’s comments on Alzheimer’s Disease guidance development

In August 2017, the National Consumers League, WomenAgainstAlzheimer's, AARP, National Association of Nurse Practitioners in Women's Health, and several other women's health advocacy organizations met with Dr. Janet Woodcock, FDA’s Director of the Center for Drug Evaluation and Research (CDER), to discuss treatments for Alzheimer’s Disease (AD). 

 

Read More →